Clinical Trial Update: A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating montelukast sodium as an episode modifier for infrequent episodic asthma in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED